AKT1 and neuroblastoma: Serum withdrawal triggers EGFR-dependent activation of the PI3-kinase/Akt pathway in neuroblastoma cells, resulting in the phosphorylation of the Sp1 transcription factor and the induction of P2X7R expression, which promotes cell proliferation in the absence of trophic support [44].